先看重点
在PREDIMED(7447名高危成人)中,含葡萄酒的良好地中海饮食依从性与较低的心血管疾病(HR 0.55;95%置信区间0.36~0.83)和全因死亡(HR 0.67)风险相关,强于不含葡萄酒时(HR 0.84,无显著性;0.77)。受戒酒者偏倚影响最小的分析和交互项均不显著,较年轻的SUN队列也未见显著的心血管关联。
证据类型
随机对照试验
解读依据
公开摘要
阅读重点
对照与不确定性
研究在问什么
地中海饮食对健康的益处已被公认,但其中的葡萄酒仍有争议。作者想知道,把葡萄酒这一项算入与否,是否会改变该饮食与心血管疾病和死亡的关联。
研究了谁,如何研究
两个西班牙队列。PREDIMED纳入7447名高危参与者,用经过验证的14项问卷评估地中海饮食依从性,其中包括一项葡萄酒条目(截断值为每周7杯)。心血管事件随访4.8年,全因死亡随访17年。另评估较年轻的SUN项目队列,共23,133名参与者,随访22年。结果为经多变量校正的风险比(HR),比较依从性良好者与较差者。
主要发现
以下为作者报告的结果。数字须连同人群和不确定性一起阅读。
- 1PREDIMED心血管疾病:不含葡萄酒时,依从性良好者HR 0.84(95%置信区间0.61~1.15,无显著性);含葡萄酒时,HR 0.55(95%置信区间0.36~0.83)。
- 2PREDIMED全因死亡:不含葡萄酒时HR 0.77(95%置信区间0.68~0.87),含葡萄酒时0.67(95%置信区间0.57~0.78)。在探索性剂量反应分析中,每天饮用3杯及以上葡萄酒者没有观察到死亡风险降低。
- 3SUN队列:与心血管疾病无显著关联;死亡方面,不含葡萄酒时HR 0.94(95%置信区间0.71~1.26),含葡萄酒时0.54(95%置信区间0.28~1.04),区间均包含无效应。
- 4合并两个队列后,地中海饮食中的葡萄酒与较低的全因死亡相关(P=.01)。
局限与不确定性
- 1受戒酒者偏倚(不饮酒者可能本来就不够健康)影响最小的分析不显著,问卷中葡萄酒条目的交互项也不显著。
- 2葡萄酒摄入仅由一个问卷条目(每周7杯为截断值)衡量,较为粗略,即使在试验队列中,据此分组的比较也属观察性。
- 3SUN队列的估计值置信区间较宽,包含无效应,且两个队列在年龄和风险上不同。
- 4作者因多个不显著的结果提醒解读需谨慎;以上结论仅依据摘要。
对日常健康的启示
这并不表明葡萄酒能改善健康,也不意味着不饮酒者应开始饮酒;证据属于关联性,也不稳固。饮酒还有其他风险,是否饮酒应与医生商量。
如何联系自己的数据
饮食日志或地中海饮食依从评分可以反映自己的饮食接近该模式的程度,长期追踪血压、体重和血脂比关注单一食物更有意义。可穿戴设备无法测量葡萄酒对心脏风险的影响。
如何理解这类证据
随机分组有助于因果推断,仍须检查分配、盲法、失访、随访时间和具体对照;标为随机试验不自动意味着高确定性。
作者的结构化摘要 English
以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。
Background and aims
The benefits of the Mediterranean diet (MedDiet) are well established. However, one component, wine, remains controversial. This study assessed the association between MedDiet (with or without wine consumption) and major cardiovascular disease (CVD) or all-cause mortality.
Methods
The PREDIMED trial included 7447 high-risk participants. Adherence to MedDiet was measured using a validated 14-item questionnaire, including one item on wine (cut-off: seven glasses/week). The CVD events were recorded over a 4.8-year follow-up, while all-cause mortality was tracked for 17 years. A younger Spanish cohort (the SUN project), including 23,133 participants followed up for 22 years, was also evaluated.
Results
In PREDIMED, compared with poor compliers with MedDiet (excluding wine), good compliers (excluding wine), had a multivariable-adjusted hazard ratio (HR) of 0.84 [95% confidence interval (CI) 0.61-1.15] for CVD. For good compliers with MedDiet (including wine), the HR for CVD was 0.55 (95% CI 0.36-0.83). For all-cause mortality, MedDiet compliers (excluding wine) had HR of 0.77 (95% CI 0.68-0.87), which was 0.67 (95% CI 0.57-0.78) for MedDiet compliers (including wine). In exploratory dose-response analyses, reduced risk for death was not present in PREDIMED participants who drank three or more glasses of wine/day. Additionally, analyses least vulnerable to threats of abstainer bias were not significant and neither were multiplicative interaction terms for the wine item in the questionnaire. In the SUN cohort, no significant associations were observed between MedDiet compliance, wine, and CVD. However, for all-cause mortality, the HR was 0.94 (95% CI 0.71-1.26) for MedDiet compliers (excluding wine) and 0.54 (95% CI 0.28-1.04) for MedDiet compliers (including wine). When pooling both cohorts, wine consumption within the MedDiet was associated with lower all-cause mortality (P = .01).
Conclusions
In PREDIMED, moderate wine consumption, as part of the MedDiet, appeared to be associated with lower mortality and CVD risk. Some non-significant associations and interactions advise caution in interpretation of these findings.
来源与署名
Wine consumption, Mediterranean diet, and cardiovascular risk in two Spanish cohorts.
Martínez-González MA, Bes-Rastrollo M, Sayon-Orea C, Ruiz-Canela M, Timiraos J, Toledo E, Sorlí JV, Salas-Salvado J, Gómez-Gracia E, Fiol M, Shröeder H, Lapetra J, Serra-Majem L, Pintó X, Barbería-Latasa M, Ros E, Babio N, Ortega C, de la Torre R, Lamuela-Raventos RM, Estruch R.
European heart journal · 2026-07-01
DOI: 10.1093/eurheartj/ehaf1081 ↗PubMed · 41667089 ↗Europe PMC · 记录的开放许可: cc by ↗摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。
MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅
来源核验日期 2026-11-01
实用健康指南
放在一起读
更早的进食窗口与更大的体重和胰岛素获益相关,优于晚间进食
汇总41项随机对照试验(2287名参与者,干预时间中位数8周)发现,限时进食比日常饮食体重低2.15 kg(95%置信区间−2.56至−1.74),而早吃比晚吃体重多降1.15 kg(95%置信区间−1.86至−0.45)。多数试验较短,只有6个研究组检验了早间进食,结局是身体和血液指标,不是心脏病发作或死亡。
BMJ Medicine
限热量饮食再加上午8点至下午4点进食窗口,1年减重无明显额外优势
139名肥胖患者都按限制热量的饮食进食,其中一组再加上上午8:00至下午4:00的进食窗口,12个月平均体重变化为−8.0 kg,单纯限热量组为−6.3 kg。净差值−1.8 kg(95%置信区间−4.0至0.4;P=0.11)无统计学意义,该区间既不能排除窗口确有获益,也不能排除毫无作用。
The New England Journal of Medicine
20人住院试验:超加工饮食让人每天多摄入508 kcal并增重
20名成年人在医院研究病房住了28天,两种菜单各吃2周、想吃多少吃多少:超加工菜单让他们每天多摄入508 kcal(±106,标准误,P=0.0001),体重增加0.9 kg;未加工菜单则让体重减轻0.9 kg。样本小、周期短、食物全程由研究方提供,既不能说明日常生活中的长期结果,也无法确定是食物的哪种特点导致多吃。
Cell Metabolism
地中海饮食加橄榄油或坚果与心血管事件减少相关(更正后的试验)
在7447名55至80岁、心血管风险较高的西班牙成年人中,被分到加特级初榨橄榄油(风险比0.69,95%置信区间0.53至0.91)或加坚果(风险比0.72,0.54至0.95)的地中海饮食组,发生主要心血管事件的风险低于被告知减少脂肪的对照组。试验存在随机化失误,2013年的报告已撤回并重新估算,证据有力但并不完美。
The New England Journal of Medicine

